A detailed history of Cibc World Markets Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 196,335 shares of GILD stock, worth $17.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
196,335
Previous 250,728 21.69%
Holding current value
$17.9 Million
Previous $17.2 Million 4.34%
% of portfolio
0.12%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$66.59 - $83.99 $3.62 Million - $4.57 Million
-54,393 Reduced 21.69%
196,335 $16.5 Million
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $2.76 Million - $3.19 Million
43,727 Added 21.12%
250,728 $17.2 Million
Q1 2024

May 13, 2024

SELL
$71.58 - $87.29 $17.6 Million - $21.5 Million
-246,246 Reduced 54.33%
207,001 $15.2 Million
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $4.31 Million - $4.89 Million
-58,865 Reduced 11.49%
453,247 $36.7 Million
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $19.3 Million - $21.1 Million
261,479 Added 104.33%
512,112 $38.4 Million
Q2 2023

Aug 04, 2023

BUY
$76.01 - $86.7 $10.4 Million - $11.8 Million
136,212 Added 119.04%
250,633 $19.3 Million
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $18.1 Million - $20.6 Million
-233,947 Reduced 67.16%
114,421 $9.49 Million
Q4 2022

Feb 09, 2023

SELL
$62.32 - $89.47 $2.84 Million - $4.08 Million
-45,650 Reduced 11.59%
348,368 $29.9 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $14.1 Million - $16.1 Million
236,543 Added 150.21%
394,018 $24.3 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $7.9 Million - $8.9 Million
-136,874 Reduced 46.5%
157,475 $9.73 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $2.92 Million - $3.66 Million
-50,463 Reduced 14.63%
294,349 $17.5 Million
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $660,348 - $749,507
10,178 Added 3.04%
344,812 $25 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $15.8 Million - $17.1 Million
233,964 Added 232.41%
334,634 $23.4 Million
Q2 2021

Aug 10, 2021

SELL
$63.47 - $69.35 $4.27 Million - $4.66 Million
-67,210 Reduced 40.03%
100,670 $6.93 Million
Q1 2021

May 07, 2021

SELL
$60.0 - $68.46 $96.3 Million - $110 Million
-1,604,361 Reduced 90.53%
167,880 $10.9 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $80.5 Million - $91.8 Million
1,421,508 Added 405.3%
1,772,241 $103 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $9.1 Million - $11.4 Million
146,459 Added 71.7%
350,733 $22.2 Million
Q2 2020

Aug 12, 2020

SELL
$72.34 - $84.0 $3.48 Million - $4.04 Million
-48,082 Reduced 19.05%
204,274 $15.7 Million
Q1 2020

May 12, 2020

SELL
$62.63 - $80.22 $7.33 Million - $9.39 Million
-117,089 Reduced 31.69%
252,356 $18.9 Million
Q4 2019

Feb 13, 2020

SELL
$61.62 - $67.78 $53.1 Million - $58.4 Million
-861,244 Reduced 69.98%
369,445 $24 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $55.7 Million - $61.5 Million
891,043 Added 262.34%
1,230,689 $78 Million
Q2 2019

Aug 13, 2019

BUY
$61.87 - $69.38 $842,607 - $944,886
13,619 Added 4.18%
339,646 $22.9 Million
Q1 2019

May 14, 2019

SELL
$62.53 - $70.05 $49.2 Million - $55.1 Million
-786,398 Reduced 70.69%
326,027 $21.2 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $5.42 Million - $7.07 Million
89,516 Added 8.75%
1,112,425 $69.6 Million
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $5.21 Million - $5.77 Million
73,082 Added 7.69%
1,022,909 $79 Million
Q2 2018

Aug 13, 2018

BUY
$64.88 - $75.68 $5 Million - $5.83 Million
77,001 Added 8.82%
949,827 $67.3 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $25.1 Million - $30.6 Million
-344,969 Reduced 28.33%
872,826 $65.8 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $12.9 Million - $15.2 Million
181,918 Added 17.56%
1,217,795 $87.2 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $74.7 Million - $88.5 Million
1,035,877
1,035,877 $83.9 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.